Ad26.COV2.S

E241393 UNEXPLORED

Ad26.COV2.S is a single-dose, adenovirus vector-based COVID-19 vaccine developed by Janssen (Johnson & Johnson) to provide protection against SARS-CoV-2 infection.

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Janssen COVID-19 Vaccine → alsoKnownAs → Ad26.COV2.S ⓘ